China Disputes Allegations Of H1N1 Under-counting Similar To SARS
This article was originally published in PharmAsia News
The Chinese Ministry of Health disputed suggestions by a medical expert that the nation was as likely to under-count the number of H1N1 patients as it did SARS patients in previous years
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.